Tuesday, 17 November 2026 Every SEC filing alert, by company
ALFA USA Filings Every alert, straight from SEC EDGAR
News

BIO-TECHNE Corp

NASDAQ: TECH · Life Sciences · 4 alerts · CIK 842023

Share price
$72.79Close, Nov 16
Market cap
$11.4B
Shares outstanding
157.06MLatest SEC cover page
Sector
Life Sciences
Industry
Biological Products, (No Diagnostic Substances)SIC 2836

Today's reference numbers: shares from the company's latest SEC cover page, price from the latest market close. Not a valuation or a recommendation. All BIO-TECHNE Corp filings on SEC EDGAR ↗

5:09 PM ET 8-K
M&A Deal

BIO-TECHNE M&A Deal with Merck KGaA, Darmstadt, Germany

Bio-Techne shareholders voted to approve the company's acquisition by Merck KGaA, Darmstadt, Germany, at a special meeting held on September 23, 2026. The transaction has also cleared the HSR Act antitrust waiting period and is expected to close by late 2026 or early 2027. Bio-Techne will become a wholly-owned subsidiary of Merck KGaA upon completion of the merger.

Counterparty
Merck KGaA, Darmstadt, Germany

Get Alerts

Get ALFA Finder alerts first

Real-time SEC filing alerts for US stocks are launching soon. Leave your details and we'll tell you the moment they go live.